Filing Details
- Accession Number:
- 0001387131-16-004575
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-14 17:01:20
- Reporting Period:
- 2016-03-10
- Filing Date:
- 2016-03-14
- Accepted Time:
- 2016-03-14 17:01:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1485508 | C. Cooper Collins | 6800 Broken Sound Parkway Nw, Third Floor Boca Raton, FL 33487 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-11 | 16,000 | $6.23 | 36,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- These shares were purchased in multiple transactions at prices ranging from $6.18 to $6.29, inclusive; the price reported reflects the weighted average price. The reporting person undertakes to provide to TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.